Olivia Finney Email and Phone Number
Olivia Finney work email
- Valid
- Valid
Olivia Finney personal email
- Valid
Olivia Finney is a Director, Translational Sciences at BioNTech US at BioNTech SE. She possess expertise in immunology, cell culture, infectious diseases, flow cytometry, molecular biology and 16 more skills.
-
Director, Translational SciencesBiontech Se Oct 2022 - PresentMainz, Rhineland-Palatinate, De -
Director, Oncology Research2Seventy Bio Nov 2021 - Oct 2022Cambridge, Massachusetts, UsTranslational lead for several cross-functional correlative research teams focused on the overall design, execution and analysis of correlative data, including clinical, manufacturing and experimental datasets, to support cellular immunotherapy trials of both blood and solid tumors. -
Director, Oncology ResearchBluebird Bio Jan 2021 - Nov 2021Somerville, Massachusetts, Us -
Associate Director, ImmunotherapyBluebird Bio Oct 2018 - Jan 2021Somerville, Massachusetts, Us -
Correlative Studies Laboratory ManagerSeattle Children'S Research Institute Oct 2016 - Oct 2018Lead of the Ben Towne Center for Childhood Cancer Research's correlative studies for chimeric antigen receptor (CAR) immunotherapy trials. Manage a GLP level research laboratory composed of a growing team of scientists, coordinators and quality staff focused on the development and application of a broad spectrum of correlative study platforms to support clinical and translational studies. Guide the scientific direction and research agenda of the study while helping to expand current and future research.
-
Research Scientist IvSeattle Children'S Research Institute May 2013 - Sep 2016Lead of the Ben Towne Center for Childhood Cancer Research's correlative studies for chimeric antigen receptor (CAR) immunotherapy trials. This involves studying the phenotype and function of the engineered T cells after they have been infused into a patient to answer key questions such as how long the cells persist and expand in vivo, whether they are able to travel from the blood to different organs, and determine how efficiently they are able to kill cancerous cells.
-
Staff ScientistSeattle Biomedical Research Institute Jan 2012 - May 2013Seattle, Wa, UsLead research in immune responses to P. falciparum vaccinations, searching for biomarkers of protection in both sub-unit and whole parasite vaccinations. Also leading projects on antigen discovery in Plasmodium vivax. Lead Scientist of the Clinical and Translational Research Laboratory (CTRL). Responsible for developing and qualifying clinical assays, writing SOPs, study plans and study reports, working under strict controlled settings, coordinating with both QAU and clinical staff.Skilled in assay optimization, functional assays, multi-color flow cytometry (10+ colors), protein arrays, cell culture. Experience in grant writing for both public (NIH) and private (MVI, Gates Foundation) funding sources, budget development and tracking, monitoring goals.Supervisory and mentor responsibilities with junior scientists. Excellent inter-personal communication skills, presenting data internally, at conferences, and to funders/collaborators. -
Post-DocSeattle Biomedical Research Institute Sep 2010 - Dec 2011Seattle, Wa, UsLead reserach in immune responses to P. falciparum vaccinations, searching for biomarkers of protection in both sub-unit and whole parasite vaccinations. Also leading projects in antigen discovery in Plasmodium vivax. Responsibilities include optimizing assays, training staff, assisting in writing grants and budgets, coordinating between various collaborators, coordinating with the clinical team and quality assurance team to start up the Clinical and Translation Research Lab (CTRL). -
Post-DocSeattle Biomedical Research Institute Feb 2009 - Aug 2010Seattle, Wa, UsImmunological studies on novel liver stage antigens of malaria in both murine and human studies. -
Phd StudentLondon School Of Hygiene And Tropical Medicine / Medical Research Council Laboratories (The Gambia) Sep 2005 - Jan 2009London, GbThe Role of Immunoregulatory Cells in Natural Immunity to Malaria based in the MRC Laboratories in The Gambia. Responsibilities include organization of small community-based studies, sensitization of communities through liaising with community leaders and community gatherings, leading teams of field workers, optimizing immunological and cell culture assays, presenting data internally and at international conferences -
Research StudentLondon School Of Hygiene & Tropical Medicine Oct 2003 - Jul 2004Innate immune responses to Plasmodium falciparum. Six months were spent at the Joint Malaria Programme, Moshi, Tanzania, carrying out experiments on natural killer cell responses to malaria.
Olivia Finney Skills
Olivia Finney Education Details
-
Imperial College LondonBiology With A Year In Research -
Lycee Francais Charles De GaulleFrench Baccalaureat
Frequently Asked Questions about Olivia Finney
What company does Olivia Finney work for?
Olivia Finney works for Biontech Se
What is Olivia Finney's role at the current company?
Olivia Finney's current role is Director, Translational Sciences at BioNTech US.
What is Olivia Finney's email address?
Olivia Finney's email address is ol****@****ail.com
What schools did Olivia Finney attend?
Olivia Finney attended Imperial College London, Lycee Francais Charles De Gaulle.
What are some of Olivia Finney's interests?
Olivia Finney has interest in Education.
What skills is Olivia Finney known for?
Olivia Finney has skills like Immunology, Cell Culture, Infectious Diseases, Flow Cytometry, Molecular Biology, Vaccines, Elisa, Laboratory, Clinical Research, Tissue Culture, Protein Chemistry, Pcr.
Free Chrome Extension
Find emails, phones & company data instantly
Aero Online
Your AI prospecting assistant
Select data to include:
0 records × $0.02 per record
Download 750 million emails and 100 million phone numbers
Access emails and phone numbers of over 750 million business users. Instantly download verified profiles using 20+ filters, including location, job title, company, function, and industry.
Start your free trial